nodes	percent_of_prediction	percent_of_DWPC	metapath
Ethosuximide—CYP3A7—Docetaxel—head and neck cancer	0.232	0.294	CbGbCtD
Ethosuximide—CYP3A7-CYP3A51P—Docetaxel—head and neck cancer	0.232	0.294	CbGbCtD
Ethosuximide—CYP3A5—Docetaxel—head and neck cancer	0.174	0.221	CbGbCtD
Ethosuximide—CYP3A4—Vinblastine—head and neck cancer	0.0825	0.104	CbGbCtD
Ethosuximide—CYP3A4—Docetaxel—head and neck cancer	0.068	0.0861	CbGbCtD
Ethosuximide—Systemic lupus erythematosus—Hydroxyurea—head and neck cancer	0.0116	0.055	CcSEcCtD
Ethosuximide—Gastrointestinal symptom NOS—Hydroxyurea—head and neck cancer	0.0109	0.0518	CcSEcCtD
Ethosuximide—Gastrointestinal symptom NOS—Fluorouracil—head and neck cancer	0.00784	0.0373	CcSEcCtD
Ethosuximide—Systemic lupus erythematosus—Docetaxel—head and neck cancer	0.00601	0.0286	CcSEcCtD
Ethosuximide—Rash erythematous—Docetaxel—head and neck cancer	0.00435	0.0207	CcSEcCtD
Ethosuximide—Breast disorder—Hydroxyurea—head and neck cancer	0.0042	0.02	CcSEcCtD
Ethosuximide—Pancytopenia—Vinblastine—head and neck cancer	0.00418	0.0199	CcSEcCtD
Ethosuximide—Euphoric mood—Fluorouracil—head and neck cancer	0.00396	0.0188	CcSEcCtD
Ethosuximide—Pancytopenia—Hydroxyurea—head and neck cancer	0.00382	0.0182	CcSEcCtD
Ethosuximide—Agranulocytosis—Vinblastine—head and neck cancer	0.00367	0.0174	CcSEcCtD
Ethosuximide—Drowsiness—Hydroxyurea—head and neck cancer	0.00358	0.017	CcSEcCtD
Ethosuximide—Lethargy—Fluorouracil—head and neck cancer	0.00342	0.0162	CcSEcCtD
Ethosuximide—Irritability—Fluorouracil—head and neck cancer	0.00319	0.0152	CcSEcCtD
Ethosuximide—Ataxia—Fluorouracil—head and neck cancer	0.00315	0.015	CcSEcCtD
Ethosuximide—Eosinophilia—Fluorouracil—head and neck cancer	0.00286	0.0136	CcSEcCtD
Ethosuximide—Leukopenia—Vinblastine—head and neck cancer	0.00275	0.0131	CcSEcCtD
Ethosuximide—Pancytopenia—Fluorouracil—head and neck cancer	0.00275	0.0131	CcSEcCtD
Ethosuximide—Leukopenia—Hydroxyurea—head and neck cancer	0.00251	0.0119	CcSEcCtD
Ethosuximide—Lethargy—Docetaxel—head and neck cancer	0.00246	0.0117	CcSEcCtD
Ethosuximide—Agranulocytosis—Fluorouracil—head and neck cancer	0.00241	0.0114	CcSEcCtD
Ethosuximide—Anorexia—Vinblastine—head and neck cancer	0.00239	0.0114	CcSEcCtD
Ethosuximide—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—head and neck cancer	0.00237	0.0113	CcSEcCtD
Ethosuximide—Ataxia—Docetaxel—head and neck cancer	0.00227	0.0108	CcSEcCtD
Ethosuximide—Nervous system disorder—Hydroxyurea—head and neck cancer	0.00224	0.0107	CcSEcCtD
Ethosuximide—Skin disorder—Hydroxyurea—head and neck cancer	0.00222	0.0106	CcSEcCtD
Ethosuximide—Abdominal pain upper—Docetaxel—head and neck cancer	0.00221	0.0105	CcSEcCtD
Ethosuximide—Breast disorder—Docetaxel—head and neck cancer	0.00218	0.0104	CcSEcCtD
Ethosuximide—Anorexia—Hydroxyurea—head and neck cancer	0.00218	0.0104	CcSEcCtD
Ethosuximide—Decreased appetite—Vinblastine—head and neck cancer	0.00218	0.0104	CcSEcCtD
Ethosuximide—Cramp muscle—Docetaxel—head and neck cancer	0.00218	0.0103	CcSEcCtD
Ethosuximide—Gastrointestinal pain—Vinblastine—head and neck cancer	0.00205	0.00975	CcSEcCtD
Ethosuximide—Somnolence—Hydroxyurea—head and neck cancer	0.00203	0.00966	CcSEcCtD
Ethosuximide—Decreased appetite—Hydroxyurea—head and neck cancer	0.00199	0.00945	CcSEcCtD
Ethosuximide—Pancytopenia—Docetaxel—head and neck cancer	0.00198	0.00943	CcSEcCtD
Ethosuximide—Abdominal pain—Vinblastine—head and neck cancer	0.00198	0.00942	CcSEcCtD
Ethosuximide—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.00197	0.00939	CcSEcCtD
Ethosuximide—Fatigue—Hydroxyurea—head and neck cancer	0.00197	0.00937	CcSEcCtD
Ethosuximide—Weight decreased—Docetaxel—head and neck cancer	0.00189	0.00899	CcSEcCtD
Ethosuximide—Hypersensitivity—Vinblastine—head and neck cancer	0.00185	0.00878	CcSEcCtD
Ethosuximide—Stevens-Johnson syndrome—Docetaxel—head and neck cancer	0.00185	0.00878	CcSEcCtD
Ethosuximide—Leukopenia—Fluorouracil—head and neck cancer	0.0018	0.00858	CcSEcCtD
Ethosuximide—Asthenia—Vinblastine—head and neck cancer	0.0018	0.00855	CcSEcCtD
Ethosuximide—Agranulocytosis—Docetaxel—head and neck cancer	0.00174	0.00826	CcSEcCtD
Ethosuximide—Diarrhoea—Vinblastine—head and neck cancer	0.00171	0.00816	CcSEcCtD
Ethosuximide—Hypersensitivity—Hydroxyurea—head and neck cancer	0.00168	0.00801	CcSEcCtD
Ethosuximide—Dizziness—Vinblastine—head and neck cancer	0.00166	0.00788	CcSEcCtD
Ethosuximide—Urinary tract disorder—Docetaxel—head and neck cancer	0.00165	0.00785	CcSEcCtD
Ethosuximide—Connective tissue disorder—Docetaxel—head and neck cancer	0.00164	0.00781	CcSEcCtD
Ethosuximide—Asthenia—Hydroxyurea—head and neck cancer	0.00164	0.0078	CcSEcCtD
Ethosuximide—Urethral disorder—Docetaxel—head and neck cancer	0.00164	0.00779	CcSEcCtD
Ethosuximide—Nervous system disorder—Fluorouracil—head and neck cancer	0.00161	0.00767	CcSEcCtD
Ethosuximide—Vomiting—Vinblastine—head and neck cancer	0.00159	0.00758	CcSEcCtD
Ethosuximide—Erythema multiforme—Docetaxel—head and neck cancer	0.00158	0.00752	CcSEcCtD
Ethosuximide—Headache—Vinblastine—head and neck cancer	0.00157	0.00747	CcSEcCtD
Ethosuximide—Anorexia—Fluorouracil—head and neck cancer	0.00157	0.00746	CcSEcCtD
Ethosuximide—Diarrhoea—Hydroxyurea—head and neck cancer	0.00156	0.00744	CcSEcCtD
Ethosuximide—Eye disorder—Docetaxel—head and neck cancer	0.00156	0.00743	CcSEcCtD
Ethosuximide—Dizziness—Hydroxyurea—head and neck cancer	0.00151	0.00719	CcSEcCtD
Ethosuximide—Immune system disorder—Docetaxel—head and neck cancer	0.00151	0.00718	CcSEcCtD
Ethosuximide—Mediastinal disorder—Docetaxel—head and neck cancer	0.00151	0.00716	CcSEcCtD
Ethosuximide—Nausea—Vinblastine—head and neck cancer	0.00149	0.00708	CcSEcCtD
Ethosuximide—Mental disorder—Docetaxel—head and neck cancer	0.00146	0.00696	CcSEcCtD
Ethosuximide—Somnolence—Fluorouracil—head and neck cancer	0.00146	0.00696	CcSEcCtD
Ethosuximide—Malnutrition—Docetaxel—head and neck cancer	0.00145	0.00692	CcSEcCtD
Ethosuximide—Vomiting—Hydroxyurea—head and neck cancer	0.00145	0.00691	CcSEcCtD
Ethosuximide—Rash—Hydroxyurea—head and neck cancer	0.00144	0.00685	CcSEcCtD
Ethosuximide—Dermatitis—Hydroxyurea—head and neck cancer	0.00144	0.00685	CcSEcCtD
Ethosuximide—Headache—Hydroxyurea—head and neck cancer	0.00143	0.00681	CcSEcCtD
Ethosuximide—Decreased appetite—Fluorouracil—head and neck cancer	0.00143	0.0068	CcSEcCtD
Ethosuximide—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.00142	0.00676	CcSEcCtD
Ethosuximide—Muscle spasms—Docetaxel—head and neck cancer	0.0014	0.00665	CcSEcCtD
Ethosuximide—Nausea—Hydroxyurea—head and neck cancer	0.00136	0.00646	CcSEcCtD
Ethosuximide—Urticaria—Fluorouracil—head and neck cancer	0.00131	0.00622	CcSEcCtD
Ethosuximide—Leukopenia—Docetaxel—head and neck cancer	0.0013	0.00619	CcSEcCtD
Ethosuximide—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—head and neck cancer	0.00123	0.00585	CcSEcCtD
Ethosuximide—Hypersensitivity—Fluorouracil—head and neck cancer	0.00121	0.00577	CcSEcCtD
Ethosuximide—Nervous system disorder—Docetaxel—head and neck cancer	0.00116	0.00554	CcSEcCtD
Ethosuximide—Skin disorder—Docetaxel—head and neck cancer	0.00115	0.00549	CcSEcCtD
Ethosuximide—Anorexia—Docetaxel—head and neck cancer	0.00113	0.00538	CcSEcCtD
Ethosuximide—Diarrhoea—Fluorouracil—head and neck cancer	0.00113	0.00535	CcSEcCtD
Ethosuximide—Dizziness—Fluorouracil—head and neck cancer	0.00109	0.00517	CcSEcCtD
Ethosuximide—Somnolence—Docetaxel—head and neck cancer	0.00106	0.00502	CcSEcCtD
Ethosuximide—Vomiting—Fluorouracil—head and neck cancer	0.00105	0.00498	CcSEcCtD
Ethosuximide—Rash—Fluorouracil—head and neck cancer	0.00104	0.00493	CcSEcCtD
Ethosuximide—Dermatitis—Fluorouracil—head and neck cancer	0.00104	0.00493	CcSEcCtD
Ethosuximide—Decreased appetite—Docetaxel—head and neck cancer	0.00103	0.00491	CcSEcCtD
Ethosuximide—Headache—Fluorouracil—head and neck cancer	0.00103	0.0049	CcSEcCtD
Ethosuximide—Gastrointestinal disorder—Docetaxel—head and neck cancer	0.00102	0.00488	CcSEcCtD
Ethosuximide—Fatigue—Docetaxel—head and neck cancer	0.00102	0.00487	CcSEcCtD
Ethosuximide—Nausea—Fluorouracil—head and neck cancer	0.000977	0.00465	CcSEcCtD
Ethosuximide—Gastrointestinal pain—Docetaxel—head and neck cancer	0.000971	0.00462	CcSEcCtD
Ethosuximide—Abdominal pain—Docetaxel—head and neck cancer	0.000938	0.00446	CcSEcCtD
Ethosuximide—Hypersensitivity—Docetaxel—head and neck cancer	0.000875	0.00416	CcSEcCtD
Ethosuximide—Asthenia—Docetaxel—head and neck cancer	0.000852	0.00405	CcSEcCtD
Ethosuximide—Diarrhoea—Docetaxel—head and neck cancer	0.000812	0.00386	CcSEcCtD
Ethosuximide—Dizziness—Docetaxel—head and neck cancer	0.000785	0.00373	CcSEcCtD
Ethosuximide—Vomiting—Docetaxel—head and neck cancer	0.000755	0.00359	CcSEcCtD
Ethosuximide—Rash—Docetaxel—head and neck cancer	0.000749	0.00356	CcSEcCtD
Ethosuximide—Dermatitis—Docetaxel—head and neck cancer	0.000748	0.00356	CcSEcCtD
Ethosuximide—Headache—Docetaxel—head and neck cancer	0.000744	0.00354	CcSEcCtD
Ethosuximide—Nausea—Docetaxel—head and neck cancer	0.000705	0.00335	CcSEcCtD
